Hydrolethalus Syndrome 1 (HYLS1) (Middle Region) Peptide
HYLS1
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all HYLS1 products
- HYLS1 (Hydrolethalus Syndrome 1 (HYLS1))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-HYLS1 antibody (Catalog #: ARP55449_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- HYLS1 (Hydrolethalus Syndrome 1 (HYLS1))
- Background
-
This protein is a protein localized to the cytoplasm. Mutations in this protein are associated with hydrolethalus syndrome.
Alias Symbols: FLJ32915, HLS
Protein Interaction Partner: C14orf1,C14orf1
Protein Size: 299 - Molecular Weight
- 34 kDa
- Gene ID
- 219844
- NCBI Accession
- NM_145014, NP_659451
- UniProt
- Q96M11
-
You are here:
